Brii Biosciences Limited (HKG:2137)
Hong Kong · Delayed Price · Currency is HKD 0.9800
-0.0250 (-2.49%)
Nov 3, 2026, 4:08 PM HKT
Brii Biosciences Market Cap
Brii Biosciences has a market cap or net worth of 707.42 million as of November 2, 2026. It is the 25,672nd most valuable company in the world and the 1,248th biggest in Hong Kong. Its market cap has decreased by 46.09% in one year.
Market Cap
707.42M
Enterprise Value
-1.39B
Revenue
40.23M
Global Rank
Country Rank
#1,248 Hong Kong
PE Ratio
n/a
ChartMarket Cap Chart
Since July 13, 2021, Brii Biosciences's market cap has decreased from 16.21B to 707.42M, a decrease of -95.64%. That is a compound annual growth rate of -44.54%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 3, 2026 | 707.42M | -30.43% |
| Dec 31, 2025 | 1.02B | 41.89% |
| Dec 31, 2024 | 716.67M | -56.90% |
| Dec 29, 2023 | 1.66B | -68.96% |
| Dec 30, 2022 | 5.36B | -77.39% |
| Dec 31, 2021 | 23.70B | 46.22% |
| Jul 13, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Hangzhou Jiuyuan Genetic Biopharmaceutical | 1.20B |
| TYK Medicines | 1.10B |
| Cloudbreak Pharma | 1.10B |
| Zhaoke Ophthalmology | 1.06B |
| CANbridge Pharmaceuticals | 1.03B |
| Sunho Biologics | 970.43M |
| JW (Cayman) Therapeutics Co. | 892.97M |
| Wuhan YZY Biopharma | 775.40M |